TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
Condition:  Lymphoblastic Leukemia Interventions:  Drug: Dexamethasone;  Drug: Mitoxantrone;  Drug: PEG asparaginase;  Drug: Bortezomib;  Drug: Vorinostat;  Drug: Mercaptopurine;  Drug: Methotrexate;  Drug: Blinatumomab;  Drug: Ziftomenib Sponsors:  Stanford University;  Pediatric Oncology Experimental Therapeutics Investigators' Consortium;  Amgen;  Lucile Packard Children's Hospital Foundation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Cancer & Oncology | Children | Dexamethasone | Leukemia | Methotrexate | Pediatrics | Research | Velcade